Purpose: Identification of Alzheimer's disease and related dementias (ADRD) subtypes is important for pharmacologic treatment and care planning, yet inaccuracies in dementia diagnoses make ADRD subtypes hard to identify and characterize.The objectives of this study were to: 1) develop a method to categorize ADRD cases by subtype and 2) characterize and compare the ADRD subtype populations by demographic and other characteristics. Methods:We identified cases of ADRD occurring during 2008-2014 from the OptumLabs Database using diagnosis codes and anti-dementia medication fills. We developed a categorization algorithm that made use of temporal sequencing of diagnoses and provider type. Results:We identified 36,838 individuals with ADRD. After application of our algorithm, the largest proportion of cases were non-specific dementia (41.2%), followed by individuals with antidementia medication but no ADRD diagnosis (15.6%). Individuals with Alzheimer's disease formed 10.2% of cases. Individuals with vascular dementia had the greatest burden of comorbid disease. Initial documentation of dementia occurred primarily in the office setting (35.1%).Discussion: Our algorithm identified six dementia subtypes and three additional categories representing unique diagnostic patterns in the data. Differences and similarities between groups provided support for the approach and offered unique insight into ADRD subtype characteristics.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.